Quantum-Si Inc at JPMorgan Healthcare Conference Transcript
Good morning, everybody. Thank you so much for joining us here today at J.P. Morgan's healthcare conference. My name is Bhavana, and I cover healthcare at J.P. Morgan.
Today, we are here with the team from Quantum-Si. I am very excited to introduce you to Jeff Hawkins, who is the CEO; and Patrick Schneider, who is the President and COO.
Over to you, Jeff.
Yes. Thank you for that introduction. I'd like to thank the organizers for the opportunity to share the Quantum-Si story with you today. Before I get in my presentation, just quickly, our Safe Harbor statement regarding forward-looking statements. If you have additional details, you can refer to our regulatory filings.
So Quantum-Si is the protein sequencing company. We have an experienced team from leading life science organizations such as Illumina, Millipore Sigma, and Ion Torrent. We ended 3Q with $372 million on the balance sheet, so we are in a secure financial position.
Our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |